Clindamycin Injection IP Satmycin600
20/06/2024 Healthcare
Price: 134113.00 ₹
Description
Clindamycin Injection IP, marketed under the brand name Satmycin-600, is a lincosamide antibiotic used to treat severe bacterial infections. It works by inhibiting bacterial protein synthesis, making it effective against infections such as intra-abdominal infections, skin and soft tissue infections, and bone infections. Satmycin-600 is administered intravenously for rapid and reliable absorption, offering a potent option for treating complex bacterial infections in hospital settings.Available in PCD Franchise for injectable range and third party manufacturing.
Comments
Saturn formulations
Individual
More Details